Chandra Bhagat Pharma Ltd IPO (CBC Pharma IPO) Detail

Jan 31, 2020 - Feb 6, 2020

Incorporated in 2003, Chandra Bhagat Pharma Limited is engaged in the marketing of lifesaving medicines in India such as Cardiovascular, Antineoplastic, Antibiotics and Hormones medicines. They provide pharmaceuticals and special chemical products in the Indian and international market.

The company has own sales force and distribution network to work under the brand name and supply products to the Health care center and Hospital. Chandra Bhagat Pharma also deals in import, supply and indenting in Active Pharmaceuticals Ingredients (API) and the intermediate.

The company has FDA approval to get formulations manufactured from a contract manufacturer. It has a presence for formulations in some therapeutic categories such as Anesthesia, Cardiovascular, Anti-cancer (Oncology), Pediatrics, Nephrology, Antiviral, Anti-fungal, and Neurology. The warehouses/ storage houses of the company are on lease agreements at Bhiwandi- Thane, Maharashtra.

Chandra Bhagat Pharma also exports Pharmaceutical Formulations to other countries like DR Congo, Bolivia and Philippines.

Competitive Strengths

1. Customer centric and order driven business model
2. Relationships with MNCs
3. Wide product portfolio including API and pharmaceuticals
4. Contract manufacturing facility
5. Presence in India and international market

Company Promoters:

Mr. Hemant Chandravadan Bhagat and Mr. Pranav Hemant Bhagat are the promoters of the company.

Company Financials:

Summary of financial Information (Restated)
Particulars For the year/period ended (₹ in Lakhs)
30-July-19 31-Mar-19 31-Mar-18 31-Mar-17
Total Assets 8,594.26 8,285.52 5,805.76 5,589.60
Total Revenue 3,344.50 10,671.83 9,773.41 9,028.11
Profit After Tax 24.88 62.59 103.38 66.03

Objects of the Issue:

The Issue Proceeds from the Fresh Issue will be utilized towards the following objects:

1. To Meet Incremental Working Capital Requirements;
2. Setting up Distribution and Warehousing Centre's;
3. General Corporate Purpose;
4. To meet Public Issue Expenses

CBC Pharma IPO Details

IPO DateJan 31, 2020 - Feb 6, 2020
Issue TypeFixed Price Issue IPO
Issue Size2,000,000 Eq Shares of ₹10
(aggregating up to ₹10.20 Cr)
Face Value₹10 Per Equity Share
IPO Price₹51 Per Equity Share
Market Lot2000 Shares
Min Order Quantity2000 Shares
Listing AtBSE SME
P/E (x)51
Market Cap (₹ Cr.)38.48

CBC Pharma IPO Tentative Date / Timetable

Bid/Offer Opens OnJan 31, 2020
Bid/Offer Closes OnFeb 6, 2020
Finalisation of Basis of AllotmentFeb 11, 2020
Initiation of RefundsFeb 13, 2020
Credit of Shares to Demat AcctFeb 13, 2020
IPO Shares Listing DateFeb 14, 2020

CBC Pharma IPO Lot Size and Price (Retail)

ApplicationLotsSharesAmount (Cut-off)
Minimum12000₹102,000
Maximum12000₹102,000

CBC Pharma IPO Promoter Holding

Pre Issue Share Holding96.72%
Post Issue Share Holding71.08%

CBC Pharma IPO Subscription Status (Bidding Detail)

CBC Pharma IPO how much subscribed?

No. of Times Issue Subscribed (BSE + NSE)

As on Date & Time

NII

RII

Total

Shares Offered

950,000

950,000

1,900,000

Feb 6, 2020 18:45

1.87x

1.44x

1.65x

CBC Pharma IPO Prospectus

CBC Pharma IPO Rating

91
3.5
Rating:Rated 3.5 stars

Vote Here ...

CBC Pharma IPO Listing Date

Listing DateFriday, February 14, 2020
BSE Script Code542934
NSE Symbol
Listing InMT
ISININE07QQ01016
IPO Price₹51 Per Equity Share
Face Value₹10 Per Equity Share

Listing Day Trading Information

.
IPO Price
Open
Low
High
Last Trade
Volume
BSE SME
₹51.00
₹51.70
₹51.00
₹52.10
₹51.75
778,000

CBC Pharma IPO Reviews / Ratings

Company Contact Information

Chandra Bhagat Pharma Ltd
323-F Bhagat Bhuvan,
Dr. Ambedkar Road,
Matunga (East) Mumbai- 400019

Phone: +91 22 2414 6154
Email: compliance@cbcpharma.net
Website: http://cbcpharma.com/

CBC Pharma IPO Registrar

Link Intime India Private Ltd
   Link Intime India Private Ltd
   C 101, 247 Park, L.B.S.Marg,
   Vikhroli (West), Mumbai - 400083

Phone: +91-22-4918 6270
Email: cbpl.ipo@linkintime.co.in
Website: http://www.linkintime.co.in

CBC Pharma IPO FAQs

  1. 1. What is CBC Pharma IPO?

    CBC Pharma IPO is a SME IPO of 2,000,000 equity shares of the face value of ₹10 aggregating up to ₹10.20 Crores.

    The issue price of the IPO is ₹51 Per Equity Share. The minimum order quantity is 2000 Shares per application and the offer type is Fixed Price Issue.

    The IPO opens on Jan 31, 2020 and closes on Feb 6, 2020.

    Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE SME.

  2. 2. When CBC Pharma IPO will open?

    The CBC Pharma IPO opens on Jan 31, 2020 and closes on Feb 6, 2020.

  3. 3. How to apply for CBC Pharma IPO?

    CBC Pharma IPO application can be done through banks using ASBA online or through stock brokers trading account using UPI. All popular banks i.e. HDFC, ICICI, and SBI offer online IPO applications. An investor can also apply directly through their broker (i.e. Zerodha, Sharekhan) using UPI as a payment method.

  4. 4. When CBC Pharma IPO allotment?

    The finalization of Basis of Allotment for CBC Pharma IPO will be done on Feb 11, 2020, and the allotted shares will be credited to your demat account by Feb 13, 2020. Check the CBC Pharma IPO allotment status.

  5. 5. When is CBC Pharma IPO listing date?

    The CBC Pharma IPO listing date is on Friday, February 14, 2020, at BSE SME.
  6. 6. What is the lot size of CBC Pharma IPO?

    CBC Pharma IPO lot size is 2000 Shares and the minimum order quantity is 2000 Shares.

Guaranteed Save 60% to 90% Brokerage

You could reduce the brokerage cost significantly by moving to another stock broker. Our expert team compared top share brokers in India to help traders. STOP paying Demat AMC, Brokerage in %, PCM Fee and High Stamp Duty today.

We can help you choosing the right broker. Contact us today...

CBC Pharma IPO Review / Comments

RAJAKUMAR
23. RAJAKUMAR  Feb 17, 2020 09:49
IPO Guru IPO Guru (1300+ Posts, 900+ Likes)
Dear Small
Sold 4 lot at 51.8
one lot holding, Now placed order at 51
Small Investor
22. Small Investor  Feb 14, 2020 14:26
IPO Guru IPO Guru (1300+ Posts, 700+ Likes)
Selling pressure now active , exit if any hold
Small Investor
21. Small Investor  Feb 14, 2020 10:11
IPO Guru IPO Guru (1300+ Posts, 700+ Likes)
Dear Raja
You Sold your 5 lot or Hold , Listing bellow Expected
Dinesh Singh
20. Dinesh Singh  Feb 14, 2020 09:56
Top Contributor Top Contributor (300+ Posts, 100+ Likes)
Sold @ 52.10 one lot.
Small Investor
20.1. Small Investor  Feb 14, 2020 10:08
IPO Guru IPO Guru (1300+ Posts, 700+ Likes)
SOLD @ 52
Johny
19. Johny  Feb 14, 2020 04:51
Top Contributor Top Contributor (300+ Posts, 400+ Likes)
All the best to all for a good listing!
RAJAKUMAR
18. RAJAKUMAR  Feb 13, 2020 12:08
IPO Guru IPO Guru (1300+ Posts, 900+ Likes)
Dear Small
I got 5/8
RAJAKUMAR
17. RAJAKUMAR  Feb 13, 2020 12:07
IPO Guru IPO Guru (1300+ Posts, 900+ Likes)
Dear Small
Rs 1.5 to 2.5 listing premium possible.
BLR
16. BLR  Feb 13, 2020 07:55
0/2 ( No allotment )
Dinesh Singh
15. Dinesh Singh  Feb 12, 2020 09:56
Top Contributor Top Contributor (300+ Posts, 100+ Likes)
Allotted 1 lot. Amount debited from bank.
Small Investor
15.2. Small Investor  Feb 12, 2020 16:34
IPO Guru IPO Guru (1300+ Posts, 700+ Likes)
Listing May be On 13th Feb ?,In Last FPO and Janu Corp also List before tentative date
So Keep Touch Top IPO Site

Name of the company Chandra Bhagat Pharma Limited
Scrip Code : 542934
Symbol :CBPL
ISIN No:.INE07QQ01016


Listing Possible Tomorrow ?






Dinesh Singh
15.3. Dinesh Singh  Feb 12, 2020 20:59
Top Contributor Top Contributor (300+ Posts, 100+ Likes)
Listing is on 14th...
Confirm by chittorgarh.
Johny
14. Johny  Feb 12, 2020 10:33
Top Contributor Top Contributor (300+ Posts, 400+ Likes)
Hiteshji
13. Hiteshji  Feb 11, 2020 15:59
Top Contributor Top Contributor (300+ Posts, 200+ Likes)
Tomorrow allotment..
Splendid
13.1. Splendid  Feb 11, 2020 16:38
Top Contributor Top Contributor (200+ Posts)
I got amount deduction message from Bank. So allotment done.
IPO FEVER
12. IPO FEVER  Feb 9, 2020 11:33
Cbc pharma grey Mkt premium 2/- Buyer
IPO FEVER
12.2. IPO FEVER  Feb 10, 2020 18:02
Ahmedabad
traderji
12.3. traderji  Feb 10, 2020 18:45
how / from where we got this premium details.
Dinesh Singh
11. Dinesh Singh  Feb 6, 2020 11:38
Top Contributor Top Contributor (300+ Posts, 100+ Likes)
Please don't apply in this.
HNI will not go above 3 times.
Dinesh Singh
11.2. Dinesh Singh  Feb 6, 2020 12:30
Top Contributor Top Contributor (300+ Posts, 100+ Likes)
Don't go by track record. See the subscription and then apply.
Small Investor
11.3. Small Investor  Feb 6, 2020 13:34
IPO Guru IPO Guru (1300+ Posts, 700+ Likes)
I take risk and applied in CBC also for 1 lot
Sayan
10. Sayan  Feb 6, 2020 13:02
We should not compare a 10cr IPO with a 4cr IPO. 1.5times NII subscription in 10cr IPO is more than 3times NII in 4cr IPO. and there is LM with good track record who can play vital role on listing day.
K joshi
9. K joshi  Feb 4, 2020 19:17
NII show good response and may give good return in long term
Darsh ipo
9.1. Darsh ipo  Feb 5, 2020 23:08
Listing game milna chahiye....sme bahut kam log long term hold karte hain...
Dinesh Singh
8. Dinesh Singh  Feb 4, 2020 19:49
Top Contributor Top Contributor (300+ Posts, 100+ Likes)
Please don't apply unless HNI subscribes more than 3 times.
K joshi
8.1. K joshi  Feb 5, 2020 13:13
Hni is oversubscribed 3 times
K joshi
8.2. K joshi  Feb 5, 2020 13:15
Sorry it is 1.50 times and not 3
Type mistake
K joshi
7. K joshi  Feb 5, 2020 10:33
Transway techno gave 10 % listing gain for small investors and SME will give normally same return.
CBC may do well as rightly NII have good response.
RAJAKUMAR
6. RAJAKUMAR  Jan 30, 2020 23:20
IPO Guru IPO Guru (1300+ Posts, 900+ Likes)
Dear Small
Eps for 2019 Mar is 1.17 pe is 43
Eps 0.46 as on July 19 and pe 110
RONW IS 4.71 as March 19 and July 1.84 (after issuing bonus shares at 7:1)
Nav as on July 19 is 25 against issue price of 51
Peer group Earum Pharma trading at 0.84 pe and Vishali Pharma 24 pe trading much lower than Candra is coming at pe of 110 (As on July 19)
Shareholder Fund is 14 Cr. (July 19)
Long term Debt is 9 Cr. and short term debt is 17Cr.
Debt is two times more than shareholder fund which is quite high.
Debt/Equity Ratio is 2.05 and it will reduce to 1.25 after issue. DRHP 168
Litigation by company is 2 (DRHP 168)
Litigation against company is 4 (involves 2 Dishonour cheque involves 27 lakh and 2.4 lakh
other 2 cases involves 11 lakh and 38 lakh.
Pending Litigation (drhp 170)
4 out of 3 is against Govt. of India. Other litigation (DRHP 170 TO 179)
Dear Small
Lot of litigation against company but amount involves is not much.
Drhp 170 to 179 no time to read other litigation
LM is Beeline so i will apply. Because so for three issues handled and all listing positive.
Since Sme stock dont look financial and other things, we need listing gain only.
That may happen i think so.
I will take risk and apply 2 application.




K joshi
6.1. K joshi  Feb 4, 2020 19:11
Very true
When beeline sure investors will earn
K joshi
5. K joshi  Feb 4, 2020 19:10
NII is giving good response. CBC has done awareness for IPO and market become good today. Long term good
Small Investor
4. Small Investor  Jan 31, 2020 13:19
IPO Guru IPO Guru (1300+ Posts, 700+ Likes)
NII is rocking Now
Small Investor
4.2. Small Investor  Feb 3, 2020 16:59
IPO Guru IPO Guru (1300+ Posts, 700+ Likes)
WAIT TILL 6TH ON LAST DAY OF IPO CLOSING
K joshi
4.3. K joshi  Feb 4, 2020 09:21
May be NII have long term strategy as HepA product will hv big demand and improve profit







Search Chittorgarh.com:

Download Our Mobile App

Android App iOS App